etrials sees losses escalate; names new CEO
eClinical specialist etrials Worldwide saw its losses quadruple in the third quarter on the back of a dip in revenues and financial charges, including a $4m asset impairment charge related to goodwill.
eClinical specialist etrials Worldwide saw its losses quadruple in the third quarter on the back of a dip in revenues and financial charges, including a $4m asset impairment charge related to goodwill.
PharmaForm's new EPAS particle engineering technology, launched at this year's AAPS in Atlanta, US, may help drugmakers improve the solubility of insoluble actives without some of the costly and time consuming processing steps used by traditional methods.
The UK Royal Commission has issued a report on the spread of nanomaterials, stating that “urgent action [is] needed on testing and regulation”.
EyeGate Pharma has been received an award from Frost & Sullivan recognising its development of ocular drug delivery technology.
Recent European legislation designed to increase the number of children in clinical trials has had a positive impact in ensuring that paediatric patients are included in medicine testing.
One of the obstacles to the development of Poland’s clinical research market is due to be removed next month, according to local consultancy firm Polish Market Research.